首页    期刊浏览 2024年09月07日 星期六
登录注册

文章基本信息

  • 标题:Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs — Georgia, 2018
  • 本地全文:下载
  • 作者:Ketevan Stvilia, ; Philip R. Spradling, ; Alexander Asatiani,
  • 期刊名称:Morbidity and Mortality Weekly Report
  • 出版年度:2019
  • 卷号:68
  • 期号:29
  • 页码:637-641
  • DOI:10.15585/mmwr.mm6829a2
  • 出版社:Centers for Disease Control and Prevention
  • 摘要:What is already known about this topic? Georgia, with a high prevalence of hepatitis C virus (HCV) infection and a high prevalence of injection drug use, launched a hepatitis C elimination program in 2015. Since 2006, needle and syringe programs (NSPs) have offered HCV antibody testing for persons who inject drugs. What is added by this report? Following the launch of the hepatitis C elimination program, the number of HCV antibody tests performed at NSPs has increased fivefold, and the number of persons with positive test results has doubled. What are the implications for public health practice? Hepatitis C testing at NSPs is an effective strategy for identifying persons with HCV infection. The program in Georgia might serve as a model for other countries.
  • 关键词:Persons Who Inject Drugs And Hepatitis C Virus; Hepatitis C Testing At Needle And Syringe Programs; Georgia Needle And Syringe Programs; Hepatitis C Elimination Program; Hepatitis C; Global Health; MMWR; Morbidity & Mortality Weekly Report; Public Health
国家哲学社会科学文献中心版权所有